Showing results (2811-2820 of 3,717) with videos related to
Sort By:
Pageof 372
Investigational New Drugs|August 11, 2010
Synthesis and antitumor activity of novel aroylthiourea derivatives of podophyllotoxinYu Zhao, Chengniu Wang, Zhonghua Wu, et al.Investigational New Drugs|August 14, 2010
Pharmacokinetic interaction involving sorafenib and the calcium-channel blocker felodipine in a patient with hepatocellular carcinomaCharline Gomo, Romain Coriat, Lionel Faivre, et al.Investigational New Drugs|August 14, 2010
A phase II study of S-1 and oxaliplatin (SOx) combination chemotherapy as a first-line therapy for patients with advanced gastric cancerSung Yong Oh, Hyuk-Chan Kwon, Sang-Ho Jeong, et al.Investigational New Drugs|August 28, 2010
Feasibility of oxaliplatin, 5-fluorouracil and leucovorin (FOLFOX-4) in cirrhotic or liver transplant patients: experience in a cohort of advanced hepatocellular carcinoma patientsRomain Coriat, Olivier Mir, Anatole Cessot, et al.Investigational New Drugs|July 8, 2010
Modulation of P-gp expression by lapatinibGráinne Dunne, Laura Breen, Denis M Collins, et al.Investigational New Drugs|June 10, 2010
The histone deacetylase inhibitor panobinostat demonstrates marked synergy with conventional chemotherapeutic agents in human ovarian cancer cell linesDaniel R Budman, Julia Tai, Anthony Calabro, et al.Investigational New Drugs|August 17, 2010
Antitumor and antiangiogenic effects of GA-13315, a gibberellin derivativeYanli Zhang, Hui Zhang, Jingbo Chen, et al.Investigational New Drugs|February 12, 2009
Trastuzumab-induced CCL20 and interleukin-8 mRNA in human whole blood ex vivoSetsuo Hasegawa, Hideaki Kato, Hiroki Yamaguchi, et al.Investigational New Drugs|January 15, 2009
A novel DNA intercalator, butylamino-pyrimido[4',5':4,5]selenolo(2,3-b)quinoline, induces cell cycle arrest and apoptosis in leukemic cellsM S Shahabuddin, Mridula Nambiar, Bibha Choudhary, et al.Investigational New Drugs|January 17, 2009
Phase III trial of standard versus dose-intensified doxorubicin, ifosfamide and dacarbazine (MAID) in the first-line treatment of metastatic and locally advanced soft tissue sarcomaJérôme Fayette, Nicolas Penel, Christine Chevreau, et al.Pageof 372